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Lymphoid follicles are primary sites for the humoral immune response. Within
the complex microenvironment ofthe lymphoid follicle, B cells receive a multitude
ofsignals that influence theirmigration and differentiation. In the germinal center,
follicular dendritic cells (FDCs)' are physically associated with B cells by forming
adense three-dimensional network. These cells play acentral role by trapping and
delivering immune complexes to B cells.
Although morphologically similar, FDCscanbedistinguished from thelymphoid
dendritic cells (interdigitating reticulumcells), which were first described by Steinman
et al. (1, 2). Whereas FDCs are localized to primary and secondary follicles, lym-
phoid dendritic cells are found in T cell-rich interfollicular areas. The latter cells
are functionally distinct in that they are potent stimulators ofT cells in autologous
and allogeneic mixed lymphocyte reactions (3-6). Consistent with their function to
fix immune complexes, FDCs express all three receptors for the third complement
component (CR1, CR2, and CR3), whereas lymphoid dendritic cells do not (6).
The cellular origin ofFDCs is still unknown. Attempts have been made to define
the lineage ofthese cells by in situ and in vitro staining with mAbs directed against
lineage-restricted and -associated antigens (7-9). These investigations demonstrated
that FDCs express CRl, CR2, and CR3, as well as the marker DRC-1. However,
the expression ofother B and myeloid markers has been more controversial. Since
germinal center B cells are in such close proximity to FDCs, it is not possible to
conclusively distinguish in situ whether staining is localized to FDCs or to B cells.
Similarly, partially enriched FDCs form dense clusters with lymphoid cells in vitro
(7) and, therefore, it has been difficulttoprecisely determine their antigenic pheno-
type. In the present study, unclustered FDCs were isolated and phenotypically charac-
terized. These cells display a unique phenotype in that they expressed both B cell
and myeloid markers, as well as many adhesion molecules. Using their antigenic
and morphologic characteristics, FDCs were isolated to homogeneity by flow cyto-
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metric cell sorting. These highly purified FDCs did not express IL-6 mRNA. It may
now become possible to further clarify the role of these cells in cell-cell interaction
and cytokine production within the microenvironment of the germinal center.
Materials and Methods
Antibodies.
￿
Antibodies used in the present study are listed Table 1. Many of the reagents
were provided by the Fourth International Workship on Human Leukocyte Differentiation
Antigens. Other antibodies were either produced in our laboratory, obtained through com-
panies (listed in Table I), or were generous gifts of the following investigators: Dr. A. Albino
(J143; Memorial Sloan-Kettering Cancer Center, New York); Dr. C. Damsky (BIE5; UCSF,
San Francisco) ; Dr. C. Dinarello (rabbit anti-IL-6; Tufts University, Boston); Dr. S. Gillis
(Immunex, Seattle); Dr. J. Griffin (904, Mol, Mo2, AML-2-23, 322, My7, IV-3 D3, My9,
L4F3, 12-8; Dana-Farber Cancer Institute, Boston); Dr. M. Hemler (TS2/7; Dana-Farber
Cancer Institute); Dr. R. Hynes (rabbit antiVLA-f3 1 ; Massachusetts Institute ofTechnology,
Cambridge); Dr. J. Johnson (63D3; Institut fur Immunoogc, Mfinchen, FRG); Dr. T.
Kishimoto (rabbit anti-rhIL-6; Institute for Molecular and Cellular Biology, Osaka, Japan);
Dr. D. Mason (R4/23; John Radcliffe Hospital, Oxford, England); Dr. C. Morimoto (2H1,
4B4, GAP P3, 2H4, 8F2; Dana-Farber Cancer Institute); Dr. J. Ritz (J2, J5, 2F12, 1OF12,
S6F1, NKH-1; Dana-Farber Cancer Institute); Dr. C. Rudd (AlA5 ; Dana-Farber Cancer In-
stitute); Dr. A. Sonnenberg (GOH3; Central Laboratory for the Netherlands, Amsterdam);
Dr. T. Springer (RR.1; Center for Blood Research, Boston); Dr. A. Wardlow (rabbit anti-
CD18; Center for Blood Research). Biotinylated Bl (CD20) and B2 (CD21) were obtained
from Coulter Immunology (Hialeah, FL). mAb 543 (CD35) was produced from a hybridoma
cell line (American Type Culture Collection, Rockville, MD). The working concentration
ofthe antibodies was confirmed by positive control stainings of reactive cell populations. Bio-
tinylation of mAbs and preparation of phycoerythrin-streptavidin conjugations were done
according to Daley (10). In all experiments mouse and rat Igs of the corresponding isotype
and preimmune rabbit serum, respectively, were used as negative controls.
Immunophenotyping.
￿
Reactivity of a large panel of antibodies with FDCs was determined
by immunoperoxidase staining on cytospin preparations of tonsillar low density cells. Cells
were spun onto microscopic slides with a cytocentrifuge (Shandon Southern Instruments Inc.,
Sewickley, PA), air dried, and fixed with acetone for 3 min. Mouse, rat, and rabbit antibody
binding was detected using affinity-purified peroxidase-conjugated antiserum of rabbit
anti-mouse Ig, (P260; Dako Corp., Glostrup, Denmark), rabbit anti-rat Ig (P162; Dako Corp.),
and swine anti-rabbit Ig (P399; Dako Corp.), respectively. Antibody reactivity was visual-
ized with 3-amino-9-ethylcarbazole (Sigma Chemical Co., St. Louis, MO) (0.25 mg/ml in
0.1 M acetate buffer, pH 5.0) with 0.003% H202. Nonspecific antibody binding to Fc
receptors was inhibited by diluting the antibodies in 10% human serum in PBS. Cells were
counterstained with Meyer's hematoxylin. To quantitate the percentage ofFDC clusters among
total FDCs, immunoperoxidase staining with mAbs against CRI, CR2, and CR3 was used.
Briefly, in all cell preparations equal numbers of FDCs were counted over a representative
microscopic field. Clustered FDCs were defined as cells that contained one or more lympho-
cytes trapped in their cytoplasmic processes. In some experiments specific antibody binding
to FDCs was confirmed by double labeling FDCs using a combination of immunoperoxidase
and immunofluorescence. Briefly, after incubation with antibodies and peroxidase-coupled
antiserum, cytospin preparations were labeled with biotinylated mAbs against CD21 (mAb
B2) and CD35 (mAb 543), followed by incubation with streptavidin/phycoerythrin complex.
Immunoperoxidase staining was subsequently developed as described above, which did not
affect the immunofluorescence staining. Antibody binding to the cell surface of viable FDCs
in suspension was visualized by using fluoresceinated goat anti-mouse Ig (Tago Inc., Burlin-
game, CA).
Cytochemical Analyses.
￿
Specific and nonspecific esterase staining was performed using
naphthol AS-D chloroacetate esterase and a-naphtylacetate esterase (Sigma Chemical Co.),
respectively, as substrate. Cytoplasmic peroxidase was detected with the substrate shown above.
PhagocytosisAssay.
￿
To test FDCs for their ability to phagocytize, low density cell prepara-SCHRIEVER ET AL.
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' Antibodies were provided by other investigators (see Materials and Methods) or from the following com-
panies: ATCC, American Type Culture Collection, Rockville, MD; BD, Becton Dickinson & Co., Moun-
tain View, CA; Coulter Immunology, Hialeah, FL: Dako Corp., Santa Barbara, CA; WS, 4th International
Workshop on Human Leukocyte Differentiation Antigens.
tions were incubated 2 h at 37°C with opsonized human RBCs. Plastic adherent monocytes
from human spleen served as positive control cells.
Isolation and Purification ofFollicular Dendritic Cells.
￿
Human tonsils were obtained immedi-
ately afternonurgent tonsillectomy, placed in a Petridish, and gently teased apart usingforceps,
knife, and stainless steelmesh. Tissue was digested with RPMI media (Gibco Laboratories,
Grand Island, NY) containing 2 mg/ml collagenase (type IV; Worthington Biochemical Corp.,
Freehold, NJ), 5 mM EDTA (pH 7.4), 10% FCS, 4 mM glutamine, 10 U/ml penicillin, 10
U/ml streptomycin, 1 mM sodium pyruvate, and 0.1 mg/ml DNase(type I; Sigma Chemical
Co.). To investigate cluster formation ofFDCs with lymphocytes under different conditions,
CD/specificity mAb Source` CD/specificity mAb Source"
CDla T6A, T6 Coulter CD35 543 ATCC
CDlb T009, T074, T070 WS CD37 HD28; G28-1 HH1 WS
CDlc T042 WS CD38 5132; GR7A4;
CD2 T11(2); T11(3) HB7 T16; ICO-20 WS
CD3 T3 CD39 G28-8; AC2 WS
CD4 T4 Coulter CD40 G28-5; EA-5 WS
CD5 T1 Coulter CDw10 Gp IIb/IIIa Dako
CD6 2H1 CD45 GAP P3
CD7 T159, T160, T161 WS CD45R 2H4
CD8 T8 Coulter NK NKH-1
CD9 J2 B5
CD10 J5 B7
CDlla 21712 Surface IgG
CD11b 904; MO1 Surface IgD
CDllc p150/95 Dako Surface IgM
CD13 My7 Surface K
CD14 AM1-2-23, 322, Mo2 Surface ),
CD16 Leu-llb BD ICAM-1 RR. 1
CD18 101712 ; S6171 VLA 1 TS2/7
CD19 B4; B-C3 ; J3-119; Coulter VLA 3 J143
CLB-CD19 WS VLA 4 8172
CD20 Bl ; 1175 ; 2H7; B-lyl Coulter VLA 5 BIE5
WS VLA 6 GOH3
CD21 B2; BU-35; 21A/5; VLA 0 chain 4114; AIA5
BU-36 WS DRC-1 R4/23 Dako
CD22 HD6; HD39 ; HD239; rhIL- Rabbit serum
G28-7 WS PCA-I Coulter
CD23 Blast 2 ; H107 ; M-L47; Factor VIII Dako
BU-38; 3-5 ; WS Epithelial
CD24 LC66; 321312; ML5 WS membrane
HB8 antigen Dako
CD25 Tac 63133 ATCC
CDw29 4B4; AIA5 HLA class I W6.32
CD30 RSC 1 Dako HLA class II 6/7; 6; 332
CD32 IV-3 D3
CD33 My9; L4F3
CD34 12-82046
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equal small tonsil pieces were digested separately for 1 h on ice, at room temperature and
at 37°C, or at room temperature in the presence of 2, 10, and 50 mM EDTA (pH 7.4). Cell
suspensions were centrifuged at 1,800 rpm for 25 min over a discontinuous gradient of 15%
(1.02 g/ml density) and 35% (1 .04 g/ml density) Percoll (Pharmacia Fine Chemicals, Upp-
sala, Sweden), and low density cell preparations enriched for FDCs were collected from the
15%/35% interphase.
Final FDC purification was achieved by labeling low density cell suspensions with mAb
322 (CD14), subsequent staining with fluoresceinated goat anti-mouse Ig (Tago Inc.), and
sorting with an EPICS cell sorter (Coulter Electronics Inc., Hialeah, FL). FDCs were sorted
using parameters of log fluorescence and log 90° light scatter, and gate windows were set
to exclude cell clusters. Cells were sorted twice to reach the highest purity possible. Both
antibodies were ultracentrifuged at 4°C with 15,000 rpm for 30 min immediately before use
to eliminate protein aggregations. Nonspecific binding to cell surface Fc receptors was blocked
by diluting the antibodies in 10 % human serum in media. Purity of the sorted FDC prepara-
tions was determined by re-analysis with flow cytometry. For two-color analyses, sorted FDCs
were labeled with biotinylated mAbs against BI (CD20) or B2 (CD21), stained with strep-
tavidin/phycoerythrin complex, and analyzed by FAGS.
RNA Purification and Polymerise Chain Reaction.
￿
SRBC receptor negative cells from human
tonsil were stimulated for 10 h with anti-Ig beads and highly purified FDCs were obtained
by cell sorting. RNA from these cells was extracted by a modification ofthe acid guanidinium
thiocyanate-phenol-chloroform isolation procedure designed for small quantities ofcells (11).
Since the number of highly purified FDCs after the sort was very small (105), gene expres-
sion of these cells was analyzed using the very sensitive technique of polymerase chain reac-
tion (PCR) (12). RNA (250-500 ng) was reverse transcribed using 200 U of Moloney murine
leukemia virus reverse transcriptase and 0.8 hg oligo-dT as primer for 1 h at 37°C. One
third of the resulting cDNA was analyzed for IL-6 or aldolase A expression by amplifying
with 5 U of Thermus aquaticus (Taq) polymerise (Perkin-Elmer Corp., Norwalk, CT) and
primers (50 pmol each) during 40 cycles of PCR (12) on a PHC-1 Programmable Dri Block
(Techne, Inc., Princeton, NJ). The sense primer for IL-6 consisted of nucleotides 200-223
and the antisense primer consisted ofnucleotides 542-517 (13). The sense primer for aldolase
consisted of a 21 nucleotide-long sequence and the antisense primer was a 23 nucleotide-long
sequence (14) (both primers as well as an oligonucleotide probe were a generous gift of Dr.
Daniel Bergsagel, Dana-Farber Cancer Institute, Boston). Every cycle included denaturation
at 94°C, annealing of primers and fragments at 37°C, and primer extension at 72°C. 16 ill
ofthe product DNA obtained by PCR was applied to a 3% NuSieve GTG/1 % Sea-Kem GTG
agarose gel . Gels were run in tris acetate EDTA buffer containing ethidium bromide at 50 V
for 3-5 h and Southern transferred onto a Zeta-Probe membrane (Bio-Rid Laboratories,
Richmond, CA). Hybridization was performed using 32p-labeled cDNA for IL-6 (kindly
provided by Dr. Steven Clark, Genetics Institute, Cambridge, MA) and a 32p-labeled 23-
base oligonucleotide probe specific for the amplified aldolase A fragment (14).
Results
Morphological Identification of FDCs.
￿
Using characteristic morphological features
of FDCs, it was possible to distinguish them from other dendritic-shaped cells, i.e.,
macrophages and interdigitating reticulum cells. As seen in Fig. 1, FDCs had four
fundamental morphologic characteristics. They were very large in size (70-100 p,m)
(Fig. 1 A) and often contained two nuclei (Fig. 1, A and B). In addition, FDCs formed
intense clusters with lymphocytes (Fig. 1, C and D) by a network of fine processes
(Fig. 1 C, arrows). Although Wright Giemsa staining demonstrated large cell size,
binuclear appearance, and acidophilic cytoplasm, it was impossible to definitively
conclude by cytochemical staining alone that a cell was an FDC. Therefore, the re-
activity of mAbs directed against CRs (CR1, CR2, CR3) was used to provide addi-
tional evidence that cells were FDCs. All anti-CR mAbs bound homogeneously to
the cell surface and the cytoplasm of FDCs and, therefore, the prominent cytologicSCHRIEVER ET AL .
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FIGURE 1 .
￿
Immunoperoxidase staining ofFDCs in low density cell preparations from human
tonsil . (A)Anti-CD14 on singleFDC; (B) anti-CD35 (CRI) on singleFDC ; (C anti-CD21 (CR2)
reveals the cellular processes ofFDCs (arrows) that retain adherent lymphocytes ; (D) anti-surface
IgD as negative control showsno reactivity with FDCs but stains adherent lymphocytes (arrows).
features of these cells could be revealed by those antibodies (Fig . 1, B and C) . Simi-
larly, mAbs directed against otherantigens expressed onFDCs, includinganti-CD14
(Fig . 1 A), demonstrated the identical staining pattern seen with anti-CR mAbs .
Fig. 1Ddepicts anexample for anegative control antibody. Antisurface IgDbound
to clustered B cells (arrows) but lacked reactivity with the FDC .
Inhibition ofLymphocyte Adherence to FDCs.
￿
During preparation of single cell sus-
pensions and density sedimentation, lymphocytes consistently adhered to FDCs,
forming tight clusters . Attempts to disrupt these aggregations by vigorous vortexing
or by incubating the cells with EDTA or cold media did not diminish the number
ofbound lymphocytes . This cluster formation presented a major problem for fur-
ther phenotypic analyses since itwasextremely difficult to distinguish mAb staining
of lymphocytes from that of FDCs .
Therefore, in an attempt to blockthe formation of cell clusters, tonsilswere manipu-
lated under a number of different conditions . Table II summarizes the results of
two representative experiments investigating if aggregate formation ofFDCs is tem-
perature dependent and if it can be influenced by chelation of Ca'-+ and Mgt+ .
FDCs were identified by their characteristic morphology and reactivity with anti-
CR mAbs . As seen in Table II, by lowering the incubation temperature during ton-
sillar digestion, the percentage of clusters could be decreased consistently. In addi-
tion, cluster formation was inhibited progressively by increasing concentrations of
EDTA, indicating that the aggregation of FDCs with lymphocytes is Ca
2+ and Mgt+
dependent . Furthermore, it wasexamined ifadherence oflymphocytes toFDCs could2048
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TABLE II
Inhibition of Cluster Formation of FDCs with Lymphocytes
Single and clustered FDCs were determined by immunoperoxidase stainings of
low density cell preparations.
be blocked with mAbs directed against adhesion molecules (anti-leukocyte func-
tion-associated antigen 1 [anti-LFA-1] and anti-intercellular adhesion molecule 1
[anti-ICAM-1]) or against CD14 and class I. Tonsils were digested in the presence
of each of these antibodies, however, no significant decrease in cluster formation
was observed.
Antigen Expression of Follicular Dendritic Cells.
￿
Using conditions that significantly
decrease cluster formation, it was possible to precisely examine the expression of
cellular antigens on FDCs. These studies were performedwith theobjective to define
lineage and to detect functionally relevant cell surface molecules. Single cell suspen-
sions prepared in the presence of EDTA contained <0.1% FDCs (Table III). By cen-
trifuging over a low density gradient, FDCs were enriched to 4-6% (Table III). In
these cell preparations, 50-70°Jo ofFDCs showed no adherent lymphocytes. Staining
with lineage-restricted mAbs directed against B cells (anti-CD20, anti-CD24) and
T cells (anti-CD2) demonstrated that the overwhelming majority (95%) of the re-
maining clustered lymphocytes were B cells, whereas <5% were T cells. By im-
munoperoxidase staining of single unclustered FDCs, mAb binding to these cells
could be confidently determined. To exclude that the binding pattern of some of
the antibodies was due to the expression or lack of certain epitopes, some of the
markers were tested with a series of different mAbs. In addition to immunoperoxi-
dase staining of fixed cytospin preparations, viable cells in suspension were also ex-
TABLE III
Purification Steps and Enrichment of FDCs from Human Tonsil
Preparation
￿
FDCs
' Determined by immunoperoxidase staining.
1 Assessed by FAGS.
Exp. FDCs 37°C
Conditions
Room
temperature
during digestion
4°C 2 mM
of tonsil
EDTA
10 mM 50 mm
170
1 Single cells 30 49 74 55 65 70
Clusters 70 51 26 45 35 30
2 Single cells 53 73 90 66 74 87
Clusters 47 27 10 34 26 13
Physical isolation
Single cell suspension <0.1'
Preparation of low density cells (35 % Percoll gradient) 4-6'
Antigen-specific purification
Sort for highly CD14 positive cells by FAGS 701
Sort of cells obtained from above sort 98.81amined forexpression ofcell surface antigens. All FDC+ mAbs (Table IV) demon-
strated reactivity with the cytoplasm of FDCs as well as with their cell surface.
FDCs demonstrated a unique lineage-restricted antigen pattern by coexpressing
B and myeloid markers. As seen inTableIV, FDCswere stained with mAbs directed
againstthe B lineage-restricted CD19 andCD21 antigens andmAbs against myeloid-
restricted antigens CD14, CD11b, and63133. However, otherB celllineage-restricted
molecules, includingCD20, CD22, and sIg(IgM, IgD, IgG, K and X), were negative
(Table V). In addition, several myeloid markers, including CD13 and CD33, were
not expressed(Table V). Antigens found on bothB andsomemyeloidcells, including
HLA class II, CD23, CD37, and CDw40, were also expressed on FDCs, whereas
CD24 was not. In contrast to the finding that some ofthe B and myeloid antigens
were found on FDCs, all Tlineage-restricted antigens, including CD3, CD6, and
CD8, were negative. In addition, anti-NKH1, which uniquely stains resting and
activated NK cells, did not bind to FDCs.
An interesting observation was that although FDCs shared antigenic properties
with B andmyeloidcells, they did notexpress theleukocytecommon antigen (CD45
and CD45R). This molecule is a marker for most hematopoietic cells and is found
on virtually all B, T, myeloid, and NKcells. Stein and colleagues (7) have previously
Antigens
Lineage-restricted antigens:
Myeloid lineage
CD14
CR3 (CD11b)
63D3
B cell lineage
CD19
CR2 (CD21)
SCHRIEVER ET AL.
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TABLE IV
Positive Reactivity of Antibodies with FDCs
Complement receptors, adhesion molecules, and Fc receptors:
Complement receptors
CR1 CD35 (C3bR)
CR2 CD21 (C3dR)
CR3
￿
CD11b (C3biR)
Adhesion molecules
VLA 3
VLA 4
VLA 5
VLA 6
VLA S chain
ICAM-1
Fc receptors
Low affinity IgE Fc receptor (CD23)
Not lineage restricted:
DRC-1
CD37
CDw40
HLA Class I
HLA Class 11
Example antibody
Mot
Mol
63133
B4
B2
543
B2
Mol
J143
8F2
BIE5
GOH3
4B4
RR1
Blast 2
R4/23
G28-1
G28-5
W6/32
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TABLE V
Negative Reactivity of Antibodies with FDCs
described an antigen, termed DRC-1, that is foundon all FDCs as well as on a subset
ofB cells. We observed that DRC-1 was strongly expressed on all FDCs, confirming
the identity of these cells. In addition, some low density B cells were positive for
DRC-1. Anti-CD30 directed against Reed-Sternberg cells was also unreactive with
FDCs. This observation is of interest since the Reed-Steinberg cells have a density
Lineage-rcstrictcd
antigens
Example
antibody
Adhesion molecules
and Fc receptors
Example
antibody
T cell lineage LFA-lee (CDlla) 21`12
CDla T6 p150/95 (CD IIc)
CDlb 7009 ,Q chain of CDI Ia,
CD2 T11 CDllb and CDl Ic 101`12
CD3 T3 gpIIb/Illa (CDw41)
C:D6 2H1 VLA 1 TS
CD7 Tl59 40-kD FcR (CD32) IV-3 D3
CD8 'I'8 Low affinity FcR
B cell lineage (CD16) Leu-I I b
CD20 B1
CD22 G28-7, HD39
B5 B5
137 B7
Surface IgG
Surface IgD
Surface IgM
Surface K
Surface
PCA-1
Myeloid lineage
CD13 My7
CD33 My9
CD34 12-8
CD38 5D2
CD39 G28-8
NK lineage
NKH-1
Lymphoid lineage
CD45 (LCA) T200
CD45R (LCAr) 2H4
Not lineage restricted
CDlc T024
CD4 T4
CD5 T1
CD9 J2
CD10 J5
CD24 HB8
CD25 [I,-2R
CD30 RSCI
Other lineages
Factor VIII
(endothelial)
EMASCHRIEVER ET AL.
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and morphology similar to FDCs (15) . Evidence that FDCs were not of epithelial
or endothelial origin is derived from their lack of reactivity with mAbs against the
epithelial membrane antigen (EMA) and factor VIII, respectively. Anti-CALLA
has been previously shown to stain a population of cells in the germinal center (16)
which to date has not been identified. Isolated FDCs were common acute lympho-
blastic leukemia antigen (CALLA) negative. These data provided support for the
idea that FDCs, although expressing B and myeloid markers, represent a unique
cell type.
Since FDCs fix and retain immune complexes, we examined these cells for the
expression of complement and Fc receptors. As stated above, FDCs demonstrated
very strong reactivity with mAbs against the three receptors for the third comple-
ment component, CR1, CR2, and CR3 (Table IV). In addition, the low affinity
IgE Fc receptor (CD23) was strongly positive on FDCs, which was of interest since
this receptor is expressed on activated B cells and monocytes. However, it was sur-
prisingto observe that the low affinity and the40-kDFc receptors (CD16and CDw32)
were not found on FDCs.
To investigate if FDCs have cell surface structures that might regulate their adhe-
sion properties in the germinal center microenvironment, mAbs against intercel-
lular and cell-matrix adhesion molecules were examined. As seen in Tables IV and
V, the majority of molecules belongingto the three subgroups of the integrin super-
family were tested . FDCs expressed most ofthe adhesion proteins of theVLA family,
including VLA-3, -4, -5, -6, and their common /3 chain, whereas VLA-1 was nega-
tive. The second subgroup of theintegrins includes LFA-1, Mol, and p150/95, which
form a group of heterodimer proteins with a homologous a chain, CDlla, CD11b,
and CD11c, and acommon /3 chain (CD18). In contrast to the broad expression with
VLA proteins, only the a chain of Mol (CD11b) was positive. A very interesting
observation was that antibodies against the corresponding (3 chain of this molecule
did not bind to FDCs, whereas reactivity was seen with other lymphocytes. This
negative result is based upon lack of staining with two anti-CD18mAbs and ahetero-
antisera againstCD18. Although LFA-1 wasnot expressedon FDCs, itsnaturalligand
ICAM-1 was strongly positive. GpIIb/IIIa, which is a member of thethird subgroup
of integrins, was also not detected on FDCs. However, this observation was not sur-
prising since this molecule is selectively expressed on platelets.
Phagocytic Activity and Cytochemical Staining .
￿
To determine if FDCs not only ex-
press some monocyte antigens but also behave functionally like monocytes, the ability
ofthese cellsto phagocytize opsonizedhuman RBCs was examined. FDCs incubated
with RBCs for 3 h at 37°C failed to ingest RBCs, whereascontrol monocytesdemon-
strated avid phagocytosis. The cytochemical pattern of FDCs, however, was similar
to that ofmonocytes. FDCs were weakly stained formonocyte-associated nonspecific
esterase, whereas they did not contain granulocyte-restricted specific esterase and
peroxidase.
Isolation ofHomogeneous Populations ofFDCs.
￿
To obtain homogeneous cell popula-
tions that would allow to study the gene expression of these cells, an isolation proce-
dure basedon the unique antigenic phenotype ofFDCs was performed. UsingCD14
as a marker for flow cytometric cell sorting, FDCs were further purified from low
density cells (4-6°Jo FDCs). This antigen was selected because it was strongly posi-
tive on all FDCs of the 45 tonsil preparations examined by in situ staining. In con-2052 FOLLICULAR DENDRITIC CELLS DISPLAY A UNIQUE PHENOTYPE
trast, mAbs against CD14 showed a significantly weaker binding to monocytes, mac-
rophages, and granulocytes and were completely negative on lymphocytes .
Using flow cytometry, FDCs could be detected by their very strong staining with
anti-CD14 . Moreover, by examining both parameters of fluorescence intensity and
log 90° light scatter, a well-demarcated FDC population could be identified (Fig .
2 A) . As seen in Fig. 2 A, brightly stained CD14' FDCs (4-7%) could be distin-
guished from a population (4-5%) expressing lower levels of CD14 (Fig . 2 A) . By
flow cytometry cell sorting with parameters specific for FDCs, an enriched cell popu-
lation (-70%) was obtained (Table III) . To isolate a homogeneous FDC prepara-
tion, these partially purified cells were resorted using the identical parameters . As
seen in Table III and depicted in Fig . 2 B, this procedure resulted in a 98.8% pure
cell preparation . As shown in Fig. 3, the highly purified cells had a large cytoplasm
and some of the cells contained two nuclei, which is a morphology identical to the
one ofFDCs in tonsillar low density cell preparations . This also demonstrated that
the sorted cells wereFDCs . In an attempt to confirm the purity and antigenic pheno-
type of this homogeneous FDC preparation, cells were labeled with biotinylated anti-
CD21 (Fig . 2 C) or anti-CD20 (Fig . 2 D) mAbs and stained with streptavidin-
phycoerythrin . As seen in Fig . 2 C, these cells uniformly expressed CD21, whereas
they were totally unreactive with anti-CD20 (Fig . 2 D) . This demonstrates that the
FDC preparation did not contain monocytes or B cells . Moreover, these findings
confirm the in situ observation that FDCs coexpress CD14and CD21 yet lackCD20 .
Analysis ofIL-6 Expression in FDCs.
￿
To further examine the role ofFDCs within
the lymphoid follicle, it was of interest to examine whether these cells produce IL-6 .
This cytokine was selected since it has been shown to be important in terminal B
cell differentiation (17) . To test ifFDCs express the IL-6 protein, immunostaining
with rabbit antiserum to IL-6 was performed . The antibody strongly stained the
cytoplasm of activated tonsillar B lymphocytes but was unreactive with FDCs (data
FIGURE 2 .
￿
Cell sorting of FDCs
to homogeneity and double la-
beling of highly purified FDCs .
(A) Staining profile of tonsillar
low density cell preparation with
anti-CD14. (B) 98.8% pureFDC
preparation obtained after cell
sorting of highly CD14' low
density cells shown inA. (C) Co-
expression of CD14 and CD21
on highly purified FDCs . (D)
Lack of reactivity of homoge-
neous FDCs with anti-CD20 .SCHRIEVER ET AL .
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FIGURE 3 .
￿
Morphology of highly purified FDCs with Wright Giemsa stain .
not shown) . In an attempt to determine whether FDCs expressed IL-6 mRNA,PCR
amplified cDNA from highly purified FDCs was examined . Activated B cells were
used as a positive control cell preparation (18) . Because ofits abundant and uniform
cellular expression, aldolase A was selected as a positive control . Fig . 4 shows the
ethidium bromide staining pattern and the corresponding Southern blot analysis
ofPCR productDNA obtained for IL-6 and aldolase A. Activated B cells were IL-
6+ (Fig . 4, A and B, lane 3), whereas FDCs were negative (Fig . 4, A and B, lane
4) . As seen in Fig. 4, A and B (lanes 1 and 2), both activated B cells and FDCs
expressed aldolase A PCR product DNA.
FIGURE 4 .
￿
IL-6 and aldolase A gene expression of
highly purified FDCs . cDNA produced byPCRfrom
activated tonsillar B cells (lanes 1 and 3) and highly
purified FDCs (lanes 2 and 4) . cDNA was amplified
using primers specific for aldolaseA (lanes I and 2)
and for IL-6 (lanes 3and 4). (A) Electrophoretic anal-
ysis of the PCR products. (B) Southern analysis of
the gel using a 32P-labeled oligonucleotide probe for
aldolase A (lanes I and 2) and a 32p-labeled cDNA
probe for IL-6 (lanes 3 and 4). The molecular sizes
of a Hae III digest of OX174 are given on the right
side of the figure .2054 FOLLICULAR DENDRITIC CELLS DISPLAY A UNIQUE PHENOTYPE
Discussion
In the present report, FDCs were purified in an attempt to examine the expres-
sion of cellular antigens that define lineage and function. In addition, these cells
were isolated to homogeneity in order to study their gene expression. FDCs were
identified by their characteristic morphology and by their expression of receptors
forthethird complement component, themyeloid-restricted antigen CD14, and the
FDC antigen DRC-1. Unclustered FDCs displayed a unique antigenic phenotype
since they expressed several B and myeloid lineage-restricted antigens, but lacked
T and NK cell antigens as well as the leukocyte common antigen. FDCs expressed
adhesion molecules, including most oftheVLA proteins, ICAM-1, and CD11b. FDCs
could be isolated to homogeneity by their intense staining with anti-CD14 using
flow cytometric cell sorting. These highly purified FDCs expressed CD14 and CD21
but lacked CD20. This antigen pattern and characteristic morphology confirmed
that these cells were, in fact, homogeneous FDC preparations. Analysis ofthe cDNA
from these highly purified cells demonstrated no mRNA for IL-6. The study sug-
gests that FDCs may belong to a unique cellular population.
Immunostaining of FDC clusters, both in situ and in suspension, have provoked
controversy. Gerdes et al. (7) observed that human FDC clusters were positive for
CRs, class I and II molecules, and monocyte markers, and therefore concluded that
these cells were most closely related to monocytes or macrophages. Humphrey et
al. (19) challenged these findings by the observation that murine FDCs do not ex-
press Ia andmacrophage markersandthat they do notoriginate from thebone marrow.
In the present study FDCs could be separated from adherent B cells, and therefore,
it was possible to more precisely demonstrate the expression of lineage-restricted
antigens. FDCs had an antigenic phenotype uncommon to any ofthe knownhema-
topoietic cells. They shared several myeloid (CD14, CD11b, 63D3) and B (CD19,
CD21) lineage-restricted antigens and did not express any of the known T or NK
cell markers. However, FDCs lacked several other important B- (sIg, CD20, CD22,
B5, B7) and myeloid (CD13, CD33, CD34, CD38, CD39)-restricted antigens. There-
fore, the expression of B- and myeloid-restricted antigens may not be sufficient to
define the lineage of these cells. Cytochemical staining and lack of phagocytosis fur-
ther suggests that these cells only partially resemble myeloid cells. The finding that
FDCs were not positive for the common leukocyte marker CD45 supports the hy-
pothesis that human FDCs do not originate from bone marrow-derived hematopoi-
etic cells. Moreover, FDCs do not appear to be of epithelial or endothelial origin .
Therefore, our results are consistent with the hypothesis that FDCs may not belong
to a classical hematopoietic cell lineage.
Since FDCs create a three-dimensional network with B cells within the germinal
center and in tissue culture, we attempted to examine those cellular antigens that
mightbe involved in interactions between these cells. The ability to bind and present
antigen-antibody-complement complexes to Blymphocytes appears to be an impor-
tant function of the FDCs (19-22). FDCs displayed a unique antigenic pattern by
expressing all three receptors for the third complement component. In addition,
one major feature of the FDCs appears to be their ability to bind to germinal center
Blymphocytes. FDCs expressed the cell-cell adhesion moleculesICAM-1 andCD11b,
which is consistent with previous in situ observations (23, 7). Our results imply that
the binding of FDCs to B cells is a dynamic, temperature-dependent process thatSCHRIEVER ET AL.
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is regulated by Cat+ andMgt+ . These conditions are crucial for the function of cell-
cell adhesion molecules, as shown for binding ofLFA-1+ lymphocytes to ICAM-1
(24) . Although clusterformation couldnot be inhibited by usingmAbs againstthese
molecules, it can not be excluded that these receptors, in addition with other adhe-
sive proteins, might indeed regulate B-FDC adhesion .
Theobservation that FDCs were stainedwithmAbs againstVLA proteinsdemon-
strates that FDCs apparently express receptors for laminin, fibronectin, and col-
lagen . These proteins belong to a group ofheterodimers with unique a chains and
acommon /3 chain (25), and some ofthem are found on a large variety of cell types
(26) . Oneoftheir majorfunctions seems to be to mediate the adhesion ofleukocytes
to extracellular matrices (27) . VLA-4 differs from the other members of theVLA
family since it may have cell-cell adhesion functions (28) . The fact that FDCs were
positive for nearly all of the VLA proteins suggests that these receptors might play
a role for FDC function.
FDCs and lymphoid dendritic cells (interdigitating reticulum cells) are morpho-
logically similar, lowdensity cells . Both cell types provide in vivoand in vitroacom-
plex microenvironment for lymphoid cells by forming extensive networks with cel-
lular processes (29-31) . This report, however, demonstrated that FDCs could be
identified as a unique cell type with phenotypic characteristics that were distinct
from thoseoflymphoid dendritic cells . In contrast to lymphoid dendritic cells, which
contain mostlyT cells in their in vitro aggregations (31), FDCs had B cells bound
within theirprocesses . In addition, the immunophenotypic profile of tonsillar FDC
differs significantly from that of isolated lymphoid dendritic cells . The latter cell :
were negative for most of the markers that are expressed on FDCs . As reported by
Hart and McKenzie (6), lymphoid dendritic cells were not stained, for example,
bymAbs againstthecomplement receptorsCRl, CR2, and CR3, themyeloidmarkers
CD14 and 63133, and theFDC antigenDRC-1. Moreover, lymphoid dendritic cells,
in contrast to FDCs, did expressthe common leukocyte antigens CD45 andCD45R.
This observation supports the notion that these cells might represent distinct cell
entities with different cellular origins . This hypothesis is supported by the finding
that lymphoid dendritic cells originate from the bone marrow (1), in contrast to FDCs,
as observed by Humphrey et al . (19) .
Several observations deserve further comment. Other investigators have reported
that FDC clusters express surface Ig andCALLA (7), whereas in this study, singly
dispersed FDCs were negative for these markers . It was of great interest that CD11b
was clearly expressed on FDCs, but its corresponding a chain (CD18) could not be
detected.A possible explanation for this observation mightbe that the level ofCD18
was too low to be detected by in situ staining technique . It was also surprising to
note that although FDCs fix immune complexes, they did not express the 40-kD
Fc receptor and the low affinity Fc receptor. However, FDCs did have low affinity
Fc IgE receptors (CD23) . The importance of this Fc receptor to FDC function is
still unknown.
Finally, isolation ofhomogeneous populations of FDCs will facilitate functional
characterization ofthese cells . It should now be possible to determine whetherthese
cells produce cytokines important forB cell differentiation . Although highly purified
FDCs do not seem to produce IL-6, these cells might secrete this or other cytokines
after appropriatestimulation . In addition to theexaminationofthe cytokine produc-2056 FOLLICULAR DENDRITIC CELLS DISPLAY A UNIQUE PHENOTYPE
tion of these cells, it will be important to study the structures that regulate FDC
function and that are involved in cell-cell adhesion. In the future, it will also be necessary
to confirm the antigenic phenotype of the FDCs by detecting the expression of the
corresponding genes.
Summary
In the present study, follicular dendritic cells (FDCs) were purified to homogeneity
in order to define the lineage and function of these cells. FDCs were identified by
their characteristic morphology and by their expression of receptors for the third
complement component, the myeloid-restricted antigen CD14, and the FDC antigen
DRC-1 . Unclustered FDCs displayed a unique antigenic phenotype since they ex-
pressed several 13- and myeloid lineage-restricted antigens, but lacked T and NK
cell antigens as well as the leukocyte common antigen. FDCs expressed adhesion
molecules, including most of the VLA proteins, intercellular adhesion molecule 1
(ICAM-1), and CDllb. FDCs could be isolated to homogeneity by their intense staining
with anti-CD14 using flow cytometric cell sorting. These highly purified FDCs ex-
pressed CD14 and CD21 but lacked CD20. This antigen pattern and characteristic
morphology confirmed that these cells were, in fact, homogeneous FDC prepara-
tions. Analysis of polymerase chain reaction-amplified cDNA from highly purified
FDCs showed no transcripts for IL-6. The isolation of homogeneous FDC popula-
tions will be important for the analysis of the functional role of FDCs within the
lymphoid follicle.
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Note added in proof: FDCs were also tested for reactivity with the blind panel antibodies of
the Fourth International Workshop on Human Leukocyte Differentiation Antigens. The cor-
responding antigens were revealed aftersubmission ofthe manuscript. In contrast to the findings
presented in this study, FDCs were stained by the blind panel antibodies against surface K
and surface IgM.
References
1 . Steinman, R. M., and Z . A. Cohn. 1973. Identification of a novel cell type in peripheral
lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. f. Exp. Med.
137:1142.
2. Steinman, R. M., G. Kaplan, M. D. Witmer, and Z. A. Cohn. 1979. Identification of
novel cell type in peripheral lymphoid organs of mice. j Exp. Med. 149:1.
3. Inaba, K., M . D. Witmer-Pack, M. Inaba, S. Muramatsu, and R. M. Steinman . 1988.
The function of Ia' dendritic cells and la- dendritic cell precursors in thymocyte mito-
genesis to lectin and lectin plus interleukin 1. f. Exp. Med. 167:149.
4. Inaba, K., R. M. Steinman, W. C . Van Voorhis, and S. Muramatsu. 1983. Dendritic
cells are critical accessory cells for thymus-dependent antibody responses in mouse and
in man. Proc. Natl. Acad Sci. USA. 80:6041.
5 . Steinman, R. M., B. Gutchinov, M . D. Witmer, and M. C. Nussenzweig. 1983. Den-SCHRIEVER ET AL .
￿
205 7
dritic cells are the principal stimulators ofthe primary mixed leukocyte reaction in mice .
J . Exp . Med . 157:613 .
6 . Hart, DN ., and J . L . McKenzie . 1988 . Isolation and characterization of human tonsil
dendritic cells . J. Exp . Med . 168:157 .
7 . Gerdes, J ., H . Stein, D. Y. Mason, and A . Ziegler. 1983 . Human dendritic reticulum
cells oflymphoid follicles : their antigenic profile and their identification as multinucleated
giant cells . Virchows Arch . B . 42 :161 .
8 . Buckley, P. J .,M . R . Smith, M . F. Braverman, and S. A . Dickson . 1987 . Human spleen
contains phenotypic subsets of macrophages and dendritic cells that occupy discrete
microanatomic locations . Am . .J. Pathol . 128:505 .
9 . Wood, G . S ., R. R . Turner, R . A . Shiuba, L . Eng, and R . A . Warnke . 1985 . Human
dendritic cells and macrophages . Am. J . Pathol. 119:73 .
10 . Daley, J . E 1988 . Immunofluorescent reagents : preparation and analysis . Lect. Notes Coastal
Estuarine Stud . 25:167 .
11 . Chomczynski, P., and N . Sacchi . 1987 . Single-step method of RNA isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction . Anal. Biochem . 162:156 .
12 . Saiki, R . K ., D. H . Gelfand, S . Stoffel, S . J . Scharf, R . Higuchi, G. T . Horn, K . B .
Mullis, and H . A . Erlich . 1988 . Primer-directed enzymatic amplification ofDNA with
a thermostable DNA polymerase. Science (Wash . DC) . 239:487 .
13 . Hirano, T, K . Yasukawa, H . Harada, T. Taga, Y . Watanaba, T. Matsuda, S.-I .
Kashiwamura, K . Nakajima, K . Koyama, A . Iwamatsu, S . Tsunasawa, F Sakiyama,
H . Matsui, Y. Takahara, T. Taniguchi, and T. Kishimoto. 1986 . Complementary DNA
for a novel human interleukin (BSF2) that induces B lymphocytes to produce immuno-
globulin . Nature (Lond.) . 324:73 .
14 . Chelly, J ., J.-C . Kaplan, P Maire, S. Gautron, and A . Kahn . 1988 . Transcription of
the dystrophin gene in human muscle and non-muscle tissues . Nature (Loud.). 333 :858 .
15 . Cotner, T., A . Das Gupta, T Papayannopoulou, and G. Stamatoyannopoulos . 1988 . Iso-
lation of Reed-Steinberg cells from lymph nodes of Hodgkin's disease patients. Blood.
73:222 .
16 . Nadler, L. M . 1986 . B cell/leukemia panel workshop : summary and comments . In Leu-
kocyte Typing II : Human B Lymphocytes . E . L . Reinherz, B . F . Haynes, L . M . Nadler,
and I . D. Bernstein, editors . Oxford University Press, Oxford . 3-43 .
17 . Muraguchi, A ., T . Hirano, B . Tang, T Matsuda, Y. Horii, K . Nakajima, and T.
Kishimoto. 1988 . The essential role of B cell stimulatory factor 2 (BSF2/Il-6) for the
terminal differentiation of B cells . J . Exp. Med . 167:332 .
18 . Freeman, G. J ., A . S. Freedman, S. N . Rabinowe, J . M . Segil, J . Horowitz, K . Rosen,
J . F. Whitman, and L . M . Nadler. 1989 . Interleukin 6 gene expression in normal and
neoplastic B cells . j Clin. Invest . In press .
19 . Humphrey, J . H ., D. Grennan, and V. Sundaram . 1984 . The origin of follicular den-
dritic cells in the mouse and the mechanism oftrapping ofimmune complexes on them .
Eur .J . Immunol . 14:859 .
20 . Szakal, A . K ., M . H . Kosco, and J . G . Tew. 1988 . A novel in vivo follicular dendritic
cell-dependent iccosome-mediated mechanism for delivery of antigen to antigen-processing
cells . J Immunol. 140:341 .
21 . Schnizlein, C . T, M . H . Kosco, A . K . Szakal, and J . G. Tew. 1985 . Follicula r dendritic
cells in suspension: identification, enrichment, and initial characterization indicating im-
mune complex trapping and lack of adherence and phagocytic activity. ,I Immunol .
134:1360 .
22 . Heinen, E ., N. Braun, P. G . Couile, J . Van Snick, M . Moeremans, N . Cormann, C .
Kinet-Denoel, and L . J . Simar. 1986 . Transfer ofimmune complexes from lymphocytes
to follicular dendritic cells . Eur. f Immunol. 16:167 .2058 FOLLICULAR DENDRITIC CELLS DISPLAY A UNIQUE PHENOTYPE
23. Dustin, M. L., R. Rothlein, A. K. Bhan, C . A . Dinarello, and T. A. Springer. 1986.
Induction by IL 1 and interferon-,
y: tissue distribution, biochemistry, and function of
a natural adherence molecule (ICAM-1) . J. Immunol. 137:245 .
24 . Marlin, S. D., and T. A. Springer. 1987. Purified intercellular adhesion molecule-I
(ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell. 51:813.
25 . Hemler, M. E. 1987. The VLA Protein Family. J. Biol. Chem. 262:3300.
26 . Hemler, M. E., C. Huang, Y. Takada, L. Schwarz, J . L. Strominger, and M. L. Clabby.
1987 . Characterization of the cell surface heterodimer VLA-4 and related peptides. J.
Biol. Chem. 262:11478.
27. Hemler, M. E. 1988. Adhesive protein receptors on hematopoietic cells. Immunol. Today.
9:109.
28. Takada, Y., M. J . Elices, C . Crouse, and M. E. Hemler. 1989. The primary structure
of the a4 subunit of VLA-4: homology to other integrins and a possible cell-cell adhe-
sion function. EMBO (Eur. Mol. Biol. Organ.) J. In press.
29. Heinen, E., C. Lilet-Leclercq, D. Y. Mason, H. Stein, J . Boniver, D. Radoux, C. Kinet-
Denoel, and L. J . Simar. 1984. Isolation of follicular dendritic cells from human tonsils
and adenoids II. Immunocytochemical characterization. Eur. J. Immunol. 14:267 .
30. Lilet-Leclercq, C., D. Radoux, E. Heinen, C. Kinet-Denoel, J . Defraigne, M. Houben-
Defresne, and L. J . Simar. 1984 . Isolation of follicular dendritic cells from human tonsils
and adenoids. I . procedure and morphological characterization. J. Immunol. 66:235.
31 . Tsai, V., and N. J. Zvaifler. 1988 . Dendritic cell-lymphocyte clusters that form spontane-
ously in rheumatoid arthritis synovial effusions differ from clusters formed in human
mixed leukocyte reactions. J. Chn. Invest. 82 :17314.